West Pharmaceutical (WST) PT Raised to $365 at UBS
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $337.47 -2.49%
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
17 Buy, 2 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
UBS analyst Gregg Orrill raised the price target on West Pharmaceutical (NYSE: WST) to $365.00 (from $356.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Freedom Broker Downgrades Workday (WDAY) to Hold
- China Mengniu Dairy Company Limited (2319:HK) (CIADY) PT Raised to HK$25 at Macquarie
- Sunny Optical Technology Group Co Ltd (2382:HK) (SNPTF) PT Raised to HK$82.35 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
